Results 201 to 210 of about 92,182 (313)
Objective Systemic sclerosis (SSc) is a rare autoimmune disease characterized by tissue fibrosis, vasculopathy, and immune dysregulation. Our objectives were to quantify the overall and site‐specific cancer risks in patients with SSc compared to the general population, examine temporal trends in cancer incidence following SSc diagnosis, and explore ...
Jihyun Na +4 more
wiley +1 more source
Deep learning-based approaches for human pose estimation in interdisciplinary physics applications. [PDF]
Zhiliang L, Zhuo L.
europepmc +1 more source
Motorized chromosome models of mitotic chromosome folding. [PDF]
Cao Z, Du C, Hou Z, Wolynes PG.
europepmc +1 more source
Author response: Decoding the physics of observed actions in the human brain
Moritz F. Wurm, Doruk Yiğit Erigüç
openalex +1 more source
Objective We assessed whether shared decision‐making (SDM) and patient acceptability, feasibility, and overall satisfaction with a computerized patient decision aid (PtDA) for patients with systemic lupus erythematosus (SLE) differs by PtDA setting, modality, and the viewing experience. Methods Patients with SLE were invited to view a self‐administered
Jasvinder A. Singh +20 more
wiley +1 more source
On the Classification of Bosonic and Fermionic One-Form Symmetries in 2 + 1 d and 't Hooft Anomaly Matching. [PDF]
Balasubramanian M +2 more
europepmc +1 more source
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley +1 more source
Integrating medical physics into an EMR-based radiology feedback system for quality improvement. [PDF]
Russ MK +5 more
europepmc +1 more source
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung +6 more
wiley +1 more source
Independent secondary dose calculation for patient-specific quality assurance: Quantitative benefit of Monte-Carlo and custom beam modeling. [PDF]
Hoffmann L, Linaa MB, Møller DS.
europepmc +1 more source

